Literature DB >> 16531477

beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells.

Masaki Shigeta1, Yukinao Shibukawa, Hideyuki Ihara, Eiji Miyoshi, Naoyuki Taniguchi, Jianguo Gu.   

Abstract

Aspects of the biological significance of the bisecting N-acetylglucosamine (GlcNAc) structure on N-glycans introduced by beta1,4-N-acetylglucosaminyltransferase III (GnT-III) in Neuro2a cell differentiation are demonstrated. The overexpression of GnT-III in the cells led to the induction of axon-like processes with numerous neurites and swellings, in which beta1 integrin was localized, under conditions of serum starvation. This enhancement in neuritogenesis was suppressed by either the addition of a bisecting GlcNAc-containing N-glycan or erythroagglutinating phytohemagglutinin (E(4)-PHA), which preferentially recognizes the bisecting GlcNAc. GnT-III-promoted neuritogenesis was also significantly perturbed by treatment with a functional blocking anti-beta1 integrin antibody. In fact, beta1 integrin was found to be one of the target proteins of GnT-III, as confirmed by a pull-down assay with E(4)-PHA. These data suggest that N-glycans with a bisecting GlcNAc on target molecules, such as beta1 integrin, play important roles in the regulation of neuritogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531477     DOI: 10.1093/glycob/cwj100

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  12 in total

1.  Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins.

Authors:  Keiko Akasaka-Manya; Hiroshi Manya; Yoko Sakurai; Boguslaw S Wojczyk; Steven L Spitalnik; Tamao Endo
Journal:  Glycoconj J       Date:  2008-06-03       Impact factor: 2.916

2.  The effect of including the C2 insert of nonmuscle myosin II-C on neuritogenesis.

Authors:  Shekhar Saha; Sumit K Dey; Arunima Biswas; Provas Das; Mahua R Das; Siddhartha S Jana
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

3.  The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function.

Authors:  Ayako Kurimoto; Shinobu Kitazume; Yasuhiko Kizuka; Kazuki Nakajima; Ritsuko Oka; Reiko Fujinawa; Hiroaki Korekane; Yoshiki Yamaguchi; Yoshinao Wada; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

4.  Involvement of beta1-integrin up-regulation in basic fibroblast growth factor- and epidermal growth factor-induced proliferation of mouse neuroepithelial cells.

Authors:  Yusuke Suzuki; Makoto Yanagisawa; Hirokazu Yagi; Yoshihiko Nakatani; Robert K Yu
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

5.  Recognition of bisecting N-acetylglucosamine: structural basis for asymmetric interaction with the mouse lectin dendritic cell inhibitory receptor 2.

Authors:  Masamichi Nagae; Kousuke Yamanaka; Shinya Hanashima; Akemi Ikeda; Kana Morita-Matsumoto; Tadashi Satoh; Naoki Matsumoto; Kazuo Yamamoto; Yoshiki Yamaguchi
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

Review 6.  Potential roles of N-glycosylation in cell adhesion.

Authors:  Jianguo Gu; Tomoya Isaji; Qingsong Xu; Yoshinobu Kariya; Wei Gu; Tomohiko Fukuda; Yuguang Du
Journal:  Glycoconj J       Date:  2012-05-08       Impact factor: 2.916

7.  Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.

Authors:  Masaki Kurogochi; Masako Mori; Kenji Osumi; Mami Tojino; Shu-Ichi Sugawara; Shou Takashima; Yuriko Hirose; Wataru Tsukimura; Mamoru Mizuno; Junko Amano; Akio Matsuda; Masahiro Tomita; Atsushi Takayanagi; Shin-Ichiro Shoda; Takashi Shirai
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

Review 8.  Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.

Authors:  Andréia Vasconcelos-Dos-Santos; Isadora A Oliveira; Miguel Clodomiro Lucena; Natalia Rodrigues Mantuano; Stephen A Whelan; Wagner Barbosa Dias; Adriane Regina Todeschini
Journal:  Front Oncol       Date:  2015-06-25       Impact factor: 6.244

9.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

Review 10.  Immune defects in Alzheimer's disease: new medications development.

Authors:  John R Cashman; Senait Ghirmai; Kenneth J Abel; Milan Fiala
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.